Home Tags Glembatumumab Vedotin

Tag: Glembatumumab Vedotin

Glembatumumab Vedotin Does Not Meet Primary Endpoint in METRIC Study

The randomized, Phase IIb METRIC Study of glembatumumab vedotin, also known as CDX-011, an antibody-drug conjugate or ADC being developed by Celldex, compared to...

Market Trend: Cancer Immunotherapy Destined for Growth

According to data provided by Allied Market Research, the global cancer immunotherapy market is expected to grow to $117.14 billion by 2022, growing at...

Phase II Study of Single-agent Glembatumumab Vedotin in Patients with Checkpoint-Refractory...

Positive, mature, results from a Phase II study of glembatumumab vedotin (Celldex Therapeutics) in patients with stage III/IV checkpoint inhibitor-refractory, and, if applicable, BRAF/MEK...
Featured Image: Nyhavn, Copenhagen, Denmark. Courtesy: © Fotolia. Used with permission.

Glembatumumab vedotin Shows Encouraging anti-tumor Activity Checkpoint Inhibitor-refractory Metastatic Melanoma

Results from a phase II trial presented in a poster at the annual meeting of the European Society of Medical Oncology, held in Copenhagen,...

Studies Show Glembatumumab Vedotin to be Effective in a Wide Range...

During the annual meeting of the American Association for Cancer Research (AACR) being held  April 16 - 20, 2016 in New Orleans, LA, Celldex...

Glembatumumab Vedotin in Patients with Metastatic gpNMB-overexpressing Triple-negative Breast Cancer

Researchers have, in the last decades, made major advances in the development of therapies for breast cancer by identifying key markers known to drive...

ADC Market to Reach US$ 3 Billion by 2018

According to a report published by Research & Markets, one of the world's largest and most respected market research resource, the global market for Antibody-drug...

Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

The glycoprotein NMB or gpNMB, a novel transmembrane protein which is overexpressed in 40% to 60% of breast cancers, promotes metastases in animal models...

FEATURED RESOURCES